{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:29:40Z","timestamp":1792603780604,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H26-Kakushinteki Gan-Ippan-061"],"award-info":[{"award-number":["H26-Kakushinteki Gan-Ippan-061"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"crossref","award":["22-5"],"award-info":[{"award-number":["22-5"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"crossref","award":["26-20"],"award-info":[{"award-number":["26-20"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12185-025-04060-7","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:20:16Z","timestamp":1756966816000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8763-0280","authenticated-orcid":false,"given":"Hiroyuki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Iijima-Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Moritake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko M.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"4060_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12185-013-1364-2","volume":"98","author":"K Horibe","year":"2013","unstructured":"Horibe K, Saito AM, Takimoto T, Tsuchida M, Manabe A, Shima M, et al. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006\u20132010): based on registry data from the Japanese Society of Pediatric Hematology. Int J Hematol. 2013;98:74\u201388.","journal-title":"Int J Hematol"},{"key":"4060_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/pbc.20944","volume":"49","author":"D Tomizawa","year":"2007","unstructured":"Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, et al. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two llconsecutive trials of Tokyo Children\u2019s Cancer Study Group. Pediatr Blood Cancer. 2007;49:127\u201332.","journal-title":"Pediatr Blood Cancer."},{"key":"4060_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.beha.2014.04.007","volume":"27","author":"MA Kutny","year":"2014","unstructured":"Kutny MA, Gregory J Jr, Feusner JH. Treatment of pediatric APL: how does the therapeutic approach differ from adults? Best Pr Res Clin Haematol. 2014;27:69\u201378.","journal-title":"Best Pr Res Clin Haematol."},{"key":"4060_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1182\/blood-2018-03-836528","volume":"132","author":"AM Testi","year":"2018","unstructured":"Testi AM, Pession A, Diverio D, Grimwade D, Gibson B, de Azevedo AC, et al. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018;132:405\u201312.","journal-title":"Blood"},{"key":"4060_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bjh.17637","volume":"195","author":"AM Testi","year":"2021","unstructured":"Testi AM, Mohamed S, Diverio D, Piciocchi A, Menna G, Rizzari C, et al. Outcome of relapsed\/refractory acute promyelocytic leukemia in children, adolescents and young adult patients - a 25-year Italian experience. Br J Haematol. 2021;195:278\u201383.","journal-title":"Br J Haematol"},{"key":"4060_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjh.14068","volume":"174","author":"H Takahashi","year":"2016","unstructured":"Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, et al. High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukemia: a nationwide prospective study by the Japanese Pediatric Leukemia\/Lymphoma Study Group. Br J Haematol. 2016;174:437\u201343.","journal-title":"Br J Haematol"},{"key":"4060_CR7","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1200\/JCO.2016.71.6183","volume":"35","author":"MA Kutny","year":"2017","unstructured":"Kutny MA, Alonzo TA, Gerbing RB, Wang YC, Raimondi SC, Hirsch BA, et al. Arsenic trioxide consolidation allows anthracycline dose reduction for pediatric patients with acute promyelocytic leukemia: report from the Children\u2019s Oncology Group phase III historically controlled trial AAML0631. J Clin Oncol. 2017;35:3021\u20139.","journal-title":"J Clin Oncol"},{"key":"4060_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1182\/blood-2004-05-1971","volume":"106","author":"AM Testi","year":"2005","unstructured":"Testi AM, Biondi A, Lo Coco F, Moleti ML, Giona F, Vignetti M, et al. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447\u201353.","journal-title":"Blood"},{"key":"4060_CR9","unstructured":"Kataoka S, Kato M, Shioda Y, Kuroda T, Hosoi H, Taga T, et al. A-large-scale cross sectional survey of health and social life for children\u2019s cancer survivors in Japan. In: 16th congress of asia continental branch of international society of paediatric oncology (SIOP Asia 2024), June 24, 2024; Yokohama, Japan."},{"key":"4060_CR10","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1200\/JCO.2011.38.4560","volume":"30","author":"C Bally","year":"2012","unstructured":"Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, et al. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL group. J Clin Oncol. 2012;30:1641\u20136.","journal-title":"J Clin Oncol"},{"key":"4060_CR11","doi-asserted-by":"publisher","first-page":"e27542","DOI":"10.1002\/pbc.27542","volume":"66","author":"MA Kutny","year":"2019","unstructured":"Kutny MA, Geyer S, Laumann KM, Gregory J, Willman CL, Stock W, et al. Outcome of pediatric acute promyelocytic leukemia patients at Children\u2019s Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (alliance). Pediatr Blood Cancer. 2019;66:e27542.","journal-title":"Pediatr Blood Cancer."},{"key":"4060_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","volume":"8","author":"MA Kutny","year":"2022","unstructured":"Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, et al. Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children\u2019s Oncology Group AAML1331 trial. JAMA Oncol. 2022;8:79\u201387.","journal-title":"JAMA Oncol"},{"key":"4060_CR13","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1200\/JCO.20.03096","volume":"39","author":"H Zheng","year":"2021","unstructured":"Zheng H, Jiang H, Hu S, Liao N, Shen D, Tian X, et al. Arsenic combined with all-trans retinoic acid for pediatric acute promyelocytic leukemia: report from the CCLG-APL2016 protocol study. J Clin Oncol. 2021;39:3161\u201370.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04060-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:02:35Z","timestamp":1768834955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4060"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04060-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DT is an editorial board member in International Journal of Hematology. Other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}